In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies
- 1 January 1992
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 60 (1) , 84-89
- https://doi.org/10.1128/iai.60.1.84-89.1992
Abstract
The role(s) of gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and interleukin-4 (IL-4) in establishment and maintenance of protective immunity to Francisella tularensis LVS in mice (C3H/HeN) was examined by selective removal of these cytokines in vivo with neutralizing antibodies. The 50% lethal dose (LD50) for mice infected intradermally with F. tularensis alone was 136,000 CFU; treatment of mice with anti-IFN-gamma or anti-TNF-alpha at the time of infection significantly reduced (P much less than 0.05) the LD50 to 2 and 5 CFU, respectively. Abrogation of protective immunity, however, was effective only when anti-IFN-gamma or anti-TNF-alpha was administered prior to day 3 postinfection. In contrast, the LD50 for mice treated with anti-IL-4 was repeatedly higher (555,000 CFU) than for controls; this difference, however, was not significant (P greater than 0.05). Thus, IL-4 may be detrimental, while IFN-gamma and TNF-alpha were clearly crucial to the establishment of protective immunity to F. tularensis during a primary infection. The importance of IFN-gamma and TNF-alpha during a secondary immune response to F. tularensis was also investigated. Spleen cells from immune mice passively transfer protective immunity to recipient mice in the absence of confounding antibody-mediated immunity. This passive transfer of immunity, however, was abrogated by treatment of recipient mice with anti-IFN-gamma or anti-TNF-alpha at the time of challenge infection. That anticytokines effectively abrogate protective immunity very early in the course of infection with F. tularensis suggests that T-cell-dependent activation of macrophages for microbicidal activity is unlikely. These T-cell-independent events early in the course of infection may suppress bacterial replication until a T-cell-dependent response ultimately clears the bacteria.Keywords
This publication has 23 references indexed in Scilit:
- Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.The Journal of Experimental Medicine, 1990
- The requirement for gamma Interferon in resistance of mice to experimental tularemiaMicrobial Pathogenesis, 1989
- Gamma interferon limits access of Listeria monocytogenes to the macrophage cytoplasm.The Journal of Experimental Medicine, 1989
- Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.The Journal of Immunology, 1989
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.The Journal of Experimental Medicine, 1989
- Interferon-γ: the Major Mediator of Resistance Against Toxoplasma gondiiScience, 1988
- γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoitesNature, 1987
- Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.Proceedings of the National Academy of Sciences, 1985
- Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 1985
- Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.The Journal of Experimental Medicine, 1982